Aclidinium Bromide; Formoterol Fumarate Patent Expiration

Aclidinium Bromide; Formoterol Fumarate is Used for managing and maintaining chronic obstructive pulmonary disease (COPD). It was first introduced by Covis Pharma Gmbh in its drug Duaklir Pressair on Mar 29, 2019.


Aclidinium Bromide; Formoterol Fumarate Patents

Given below is the list of patents protecting Aclidinium Bromide; Formoterol Fumarate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Duaklir Pressair US10085974 Dosage and formulation Mar 13, 2029 Covis
Duaklir Pressair US11000517 Dosage and formulation Mar 13, 2029 Covis
Duaklir Pressair US8051851 Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler Apr 22, 2027 Covis
Duaklir Pressair USRE46417 Quinuclidine derivatives and their use as muscarinic M3 receptor ligands Feb 10, 2025 Covis
Duaklir Pressair US6681768 Powder formulation disintegrating system and method for dry powder inhalers Aug 07, 2022

(Expired)

Covis
Duaklir Pressair US10034867 Quinuclidine derivatives and medicinal compositions containing the same Jul 07, 2020

(Expired)

Covis
Duaklir Pressair US10588895 Quinuclidine derivatives and medicinal compositions containing the same Jul 07, 2020

(Expired)

Covis
Duaklir Pressair US7078412 Quinuclidine derivatives and medicinal compositions containing the same Jul 07, 2020

(Expired)

Covis
Duaklir Pressair US7750023 Quinuclidine derivatives and medicinal compositions containing the same Jul 07, 2020

(Expired)

Covis
Duaklir Pressair US8129405 Quinuclidine derivatives and medicinal compositions containing the same Jul 07, 2020

(Expired)

Covis
Duaklir Pressair US9056100 Quinuclidine derivatives and medicinal compositions containing the same Jul 07, 2020

(Expired)

Covis
Duaklir Pressair US9333195 Quinuclidine derivatives and medicinal compositions containing the same Jul 07, 2020

(Expired)

Covis



Aclidinium Bromide; Formoterol Fumarate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List